[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"emotional-dysregulation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:emotional-dysregulation":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,13,0,[8,54,90,116,152,181,229,250,283,316,345,378,402],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100639512","integrated-motivational-interviewing-and-rational-emotive-behavior-therapy-intervention-for-non-suicidal-self-injury-among-malaysian-primary-school-students-a-feasibility-trial-protocol-100639512",false,"NCT07627061","Integrated Motivational Interviewing and Rational Emotive Behavior Therapy Intervention for Non-Suicidal Self-Injury Among Malaysian Primary School Students: A Feasibility Trial Protocol","The Feasibility and Preliminary Effects of an Integrated Motivational Interviewing and Rational Emotive Behavior Therapy (MI-REBT) Intervention on Non-Suicidal Self-Injury, Emotional Dysregulation, and Readiness for Change Among Malaysian Primary School Students: A Trial Protocol","MIND-SET","Inclusion Criteria:\n\n* Primary school students aged 12 years old.\n* Students identified with Non-Suicidal Self-Injury (NSSI) behaviour through school mental health screening and assessment procedures.\n* Able to understand and participate in group counselling sessions.\n* Written informed consent obtained from parents or guardians.\n* Assent obtained from participating students.\n\nExclusion Criteria:\n\n* Students currently receiving intensive psychiatric treatment or psychological -intervention for severe mental health conditions.\n* Students identified with active suicidal intent requiring immediate clinical intervention.\n* Students with severe cognitive or developmental impairments that may interfere with participation in group intervention activities.\n* Students who are unable to attend the scheduled intervention sessions consistently.","ALL","12 Years",{"count":20,"type":21},105,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to evaluate the feasibility and preliminary effects of the MIND-SET Intervention Module, an integrated Motivational Interviewing and Rational Emotive Behavior Therapy (MI-REBT) intervention, among Malaysian primary school students involved in Non-Suicidal Self-Injury (NSSI) behaviour. The module is designed to reduce self-injurious behaviour, improve emotional regulation, and enhance readiness for change among 12-year-old students in school settings. This study will use a quasi-experimental design involving three groups: a MIND-SET intervention group, a PRISMA Mental Health Module group, and a treatment-as-usual group. Data will be collected at pre-intervention, post-intervention, and follow-up stages using validated psychological instruments. The findings are expected to support the development of culturally responsive, school-based mental health interventions for children involved in NSSI behaviour in Malaysia.",[27,28],"Non-Suicidal Self-Injury","Emotional Dysregulation",[30,31,32,33,34,35,36,37,38,39,40],"Non-suicidal self-injury","NSSI","Primary school students","Children","Emotional dysregulation","Readiness for change","Motivational Interviewing","Rational Emotive Behavior Therapy","School counselling","Malaysia","MIND-SET Intervention Module","NOT_YET_RECRUITING","2026-05-31",{"date":44,"type":45},"2026-06-04","ACTUAL",{"date":47,"type":21},"2026-08",{"date":49,"type":21},"2026-12",{"name":51,"class":52},"Universiti Utara Malaysia","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":11,"sex":62,"minAge":63,"maxAge":4,"enrollmentInfo":64,"targetDuration":66,"studyType":67,"phases":4,"briefSummary":68,"conditions":69,"keywords":74,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":53},"100637591","nlp-analysis-of-weekly-narratives-for-dynamic-clinical-assessment-in-sud-100637591","NCT07595614","NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD","Analysis of Weekly Narratives Using Natural Language Processing in Patients Undergoing Residential Rehabilitation: A Hybrid Approach for the Dynamic Assessment of Clinical Processes","DYNA-NLP","Inclusion Criteria:\n\n1. Clinical diagnosis of severe substance use disorder (polydrug use, including cocaine, methamphetamines, alcohol, and\u002For cannabis), confirmed by the center's admission assessment.\n2. Male sex (all participants in the center's residential program are male).\n3. Age 18 years or older.\n4. Current resident of the participating residential rehabilitation center in Mexico.\n5. Completed at least four weeks of residential treatment at the time of study enrollment.\n6. Able to write coherent weekly narratives in Spanish (no severe cognitive impairment or active psychosis).\n7. Willing to provide written informed consent.\n\nExclusion Criteria:\n\n1. Presence of acute psychotic symptoms that interfere with the ability to write or understand the study procedures.\n2. Severe cognitive impairment (e.g., due to traumatic brain injury, intellectual disability) that prevents meaningful narrative production.\n3. Inability to comply with weekly narrative writing (e.g., illiteracy, severe visual impairment).\n4. Planned discharge from the residential program within less than 4 weeks from enrollment.\n5. Enrollment in another interventional clinical trial that could confound the interpretation of outcomes.","MALE","18 Years",{"count":65,"type":21},35,"20 Weeks","OBSERVATIONAL","This prospective observational study follows adults undergoing residential rehabilitation for severe substance use disorders at a specialized treatment center in Mexico. Participants provide weekly written narratives describing their emotions, challenges, coping strategies, and treatment experiences, and complete validated psychological questionnaires every two weeks, including the Generalized Anxiety Disorder-7 (GAD-7), Environmental Reward Observation Scale (EROS), Automatic Thoughts Questionnaire-8 (ATQ-8), and Behavioral Activation for Depression Scale (BADS).\n\nThe study applies natural language processing (NLP) and machine learning methods to analyze participants' narratives and identify emotional, cognitive, and behavioral patterns associated with clinical change over time. Narrative-derived features are combined with questionnaire scores to generate a dynamic clinical risk representation that may help detect early signs of psychological worsening or improvement during residential treatment.\n\nParticipants continue receiving standard residential care, and the study does not modify treatment decisions or clinical interventions. Up to 35 participants with sufficient longitudinal follow-up data will be included in the primary analysis. Data collection is expected to continue through September 2026.",[70,71,72,28,73],"Substance Use Disorder (SUD)","Addiction","Anxiety","Rumination - Thoughts",[75,76,77,78,79],"Natural Language Processing","Machine Learning","Behavioral Activation","Automatic Thoughts","Residential Rehabilitation","RECRUITING","2026-05-14",{"date":83,"type":45},"2026-05-19",{"date":85,"type":45},"2025-05-25",{"date":87,"type":21},"2026-09",{"name":89,"class":52},"Lauro Gutiérrez Castro",{"id":91,"slug":92,"hasResults":11,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":63,"enrollmentInfo":98,"targetDuration":100,"studyType":67,"phases":4,"briefSummary":101,"conditions":102,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":53},"100626064","parent-adolescent-relationships-emotional-regulation-and-hrv-in-adolescents-with-depression-100626064","NCT07430774","Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression","CONNECT Study: Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression","CONNECT","Inclusion Criteria:\n\n1. Aged 12-18 years at the time of screening.\n2. Current Major Depressive Disorder (MDD) documented in the electronic medical record by a licensed clinician; diagnosis verified using the Mental Health History - Parent Form.\n3. Lives with a parent\u002Flegal guardian at least 50% of the time, confirmed on the Demographics Form.\n4. Able and willing to provide assent, with a parent\u002Flegal guardian able and willing to provide informed consent.\n5. Willingness to comply with all study procedures, including wearing a Fitbit Charge 5 for 7 nights, syncing the device through a compatible smartphone, and completing all required assessments (DERS-36, PHQ-9, anthropometrics, Youth Activity Profile, caffeine logs, PACHIQ-R).\n6. Primary caregiver willing to participate, including completion of the PACHIQ-R (Caregiver).\n7. If taking antidepressant medication, must be on a stable dose for at least 4 weeks before screening, verified on the Self-Administered Comorbidity Questionnaire.\n8. English-speaking adolescent and caregiver, as all measures used in the study are validated in English.\n9. Available for two in-person study visits within the study period.\n\nExclusion Criteria\n\n1. Medical conditions affecting autonomic function or HRV (arrhythmia, congenital heart disease, cardiomyopathy, Type 1 or Type 2 diabetes, thyroid disorders, or moderate-to-severe sleep apnea), as reported on the Self-Administered Comorbidity Questionnaire.\n2. Use of medications known to affect heart rate or HRV, including beta-blockers, calcium channel blockers, antiarrhythmics, tricyclic antidepressants, stimulants, or antipsychotics, as documented on the NIMH Concomitant Medication Log.\n3. Active substance use, including nicotine\u002Ftobacco, alcohol, marijuana, recreational drugs, or energy drinks, as assessed by the Drug Use Screening Inventory.\n4. Habitual high caffeine intake (\\>200 mg\u002Fday, equivalent to \\>4 cups of coffee or \\>2 cans of caffeinated soda per day), as assessed by a caffeine screening question during eligibility screening.\n5. Psychotic disorders or active psychotic symptoms, as reported on the Mental Health History Questionnaire (Parent) and the Self-Administered Comorbidity Questionnaire.\n6. Acute suicidal ideation requiring immediate intervention, defined as endorsement of agree and strongly agree on items 14-16 of the Concise Health Risk Tracking Self-Report (CHRT-SR), indicating active suicide risk.\n7. Severe cognitive or intellectual impairment interfering with study participation, determined during eligibility screening based on parent report on the Mental Health History Questionnaire and observed inability to complete screening or consent procedures.\n8. Current eating disorder diagnosis (anorexia nervosa, bulimia nervosa, or binge eating disorder), as reported on the Mental Health History Questionnaire.\n9. Concurrent participation in another study involving wearable devices or daily monitoring, as reported on the Eligibility Screening Form.\n10. Skin conditions or sensitivities prevent continuous wear of a wrist-worn device reported on the Eligibility Screening Form.",{"count":99,"type":21},74,"1 Week","This cross-sectional study examines associations among heart rate variability (HRV), emotional dysregulation, and parent-adolescent relationship quality in adolescents with Major Depressive Disorder (MDD). We hypothesize that lower HRV will be linked to greater emotional dysregulation and that more supportive parent-adolescent relationships will correlate with higher HRV. Participants will wear a Fitbit Charge 5 during nighttime sleep for 7 consecutive nights and complete validated measures of emotional regulation and relationship quality.",[28,103,104,105,106],"HRV","Adolescent","Family Relationship","Depression","2026-04-29",{"date":109,"type":45},"2026-05-06",{"date":111,"type":21},"2026-07-01",{"date":113,"type":21},"2027-05-01",{"name":115,"class":52},"University of Texas Southwestern Medical Center",{"id":117,"slug":118,"hasResults":11,"nctId":119,"briefTitle":120,"officialTitle":121,"acronym":122,"eligibilityCriteria":123,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":63,"enrollmentInfo":124,"targetDuration":4,"studyType":22,"phases":126,"briefSummary":127,"conditions":128,"keywords":134,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":53},"100636006","a-scalable-trans-diagnostic-intervention-targeting-adolescent-agency-supported-by-conversational-ai-agencia-100636006","NCT07560072","A Scalable Trans Diagnostic Intervention Targeting Adolescent Agency Supported by Conversational AI (AGENCIA)","A Randomized Controlled Trial Protocol of a Scalable Trans Diagnostic Intervention Targeting Adolescent Agency Supported by Conversational AI","AGENCIA","Inclusion Criteria:\n\n* Adolescents aged 12 to 18 years at enrollment.\n* Presence of emotional or behavioral difficulties causing functional interference (e.g., irritability, impulsivity, emotional dysregulation, conflicts at home or school, avoidance).\n* Difficulties compatible with neurodevelopmental profiles, regardless of formal diagnosis.\n* Ability to use digital materials through a personal device and basic reading skills in Spanish.\n* Availability to attend assessments and participate in the intervention and follow-up schedule.\n* Informed consent from caregivers and assent from the adolescent.\n\nExclusion Criteria:\n\n* Acute clinical risk at pre-screening or screening (e.g., imminent self-harm risk, severe agitation, aggression, disorganized behavior, or unsafe behaviors requiring immediate clinical care).\n* Score of \"Severe\" on any of the three HoNOSCA screening items (self-harm, substance-related problems, or bullying\u002Fsocial problems).\n* Uncompensated sensory, motor, or language barriers preventing valid completion of assessments or participation (e.g., severe visual or hearing impairment, significant receptive\u002Fexpressive language difficulties, motor limitations preventing device use).\n* Intellectual disability defined by screening tools: ABAS-II GAC ≤ 70 or Kaufman Brief Intelligence Test Composite Intelligence Quotient ≤ 70.\n* Any condition judged by the clinical team to require immediate alternative care or that would prevent safe participation.",{"count":125,"type":21},465,[24],"The aim of this clinical trial is to evaluate whether AGENCIA, a brief psychological program supported by digital technology and artificial intelligence, can help reduce emotional and behavioral difficulties in adolescents aged 12 to 18. These difficulties may include irritability, impulsive behaviors, conflicts at home or at school, or difficulties in managing intense emotions. The study also aims to determine whether the effects are similar across adolescents with different symptom profiles or neurodevelopmental characteristics.\n\nParticipants will be randomly assigned to one of three groups:\n\nAGENCIA Digital: a self-guided online version completed at home. AGENCIA in-person with a digital assistant: a clinician-delivered version supported by an interactive digital assistant to guide the exercises.\n\nDigital psychoeducation (control): a self-guided online program providing general information about adolescent well-being.\n\nThe main research questions are:\n\nDoes AGENCIA reduce overall emotional and behavioral difficulties? Does the program improve functioning, family accommodation, and personal agency (a young person's sense of being able to act and make changes)? Are the effects similar across adolescents with different profiles or neurodevelopmental characteristics?\n\nParticipants will:\n\n* Complete three structured sessions depending on their assigned group.\n* Complete brief online questionnaires at baseline (T0), immediately after the sessions (T1), and at 1-month (T2) and 6-month (T3) follow-ups.\n* Receive brief phone calls during follow-ups to support questionnaire completion.\n\nA total of 465 adolescents will take part in the study. Participation is voluntary and does not replace usual clinical care. The study does not involve medication or invasive procedures, and all digital tools operate within secure institutional systems.",[129,130,131,28,132,133],"Irritability","Neurodevelopmental Disorders","Impulsivity","Distress, Emotional","Distress, Psychological",[135,136,137,138,139,140,141,142],"Adolescents","Randomized controlled trial","Personal Agency","Digital health intervention","Neurodevelopmental disorders","Family accommodation","Conversational AI","Trans diagnostic interventions","2026-04-23",{"date":145,"type":45},"2026-04-30",{"date":147,"type":21},"2026-04-01",{"date":149,"type":21},"2028-12-31",{"name":151,"class":52},"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla",{"id":153,"slug":154,"hasResults":11,"nctId":155,"briefTitle":156,"officialTitle":157,"acronym":158,"eligibilityCriteria":159,"healthyVolunteers":160,"sex":17,"minAge":161,"maxAge":18,"enrollmentInfo":162,"targetDuration":4,"studyType":22,"phases":164,"briefSummary":166,"conditions":167,"keywords":168,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":171,"lastUpdatePostDateStruct":172,"startDateStruct":174,"completionDateStruct":176,"leadSponsor":178,"locationsCount":180},"100617809","early-phase-1-the-mind-study-the-mghmit-investigation-of-nac-on-dysregulation-100617809","NCT07323446","The MIND Study: The MGH\u002FMIT Investigation of NAC on Dysregulation","8-Week Double-Blind, Randomized Controlled Study of N-Acetylcysteine and Neuroimaging in Children Ages 6-12 With Emotional Dysregulation","MIND","Inclusion Criteria:\n\n\\- Emotional Dysregulation Group\n\n1. Male or female subjects, 6-12 years of age.\n2. Current symptoms of emotional dysregulation as indicated by combined T-scores on the Child Behavior Checklist \\> 180 on the Anxiety\u002FDepression + Aggression + Attention subscales.\n3. Score 15 or above on the clinician YMRS\n4. Subjects and their legal representative must have a level of understanding sufficient to communicate intelligently with the investigator and study coordinator, and to cooperate with all tests and examinations required by the protocol.\n5. Subjects and their legal representative must be considered reliable.\n6. Each subject and his\u002Fher authorized legal representative must understand the nature of the study. The subject's authorized legal representative must provide written consent and the subject must provide written assent.\n7. Subject must have access to a computer with a camera, speaker, microphone, and internet connection.\n8. Subject must be willing to refrain from treatment changes during the study protocol.\n\nTypically Developing Control Group\n\n1. Age-, sex-matched with ED participants.\n2. No significant traits of ED as screened by parent and clinician YMRS both under scores of 6\n3. No previous psychiatric history as confirmed by clinician interview\n4. No significant psychopathology as screened on the CBCL (Subdomain T-scores \\\u003C60).\n5. Participant weight is above the 5th percentile and below the 95th percentile, per CDC child BMI categories (https:\u002F\u002Fwww.cdc.gov\u002Fobesity\u002Fbasics\u002Fchildhood-defining.html)\n\nExclusion Criteria:\n\n1. Investigator and his\u002Fher immediate family (defined as the investigator's spouse, parent, child, grandparent, or grandchild).\n2. Serious or unstable illness including hepatic, renal, gastroenterological, respiratory, cardiovascular (including ischemic heart disease), endocrinologic, neurologic, immunologic, or hematologic disease.\n3. History of bleeding diathesis, including those with von Willebrand disease.\n4. Uncorrected hypothyroidism or hyperthyroidism.\n5. History of sensitivity to N-acetylcysteine, a history of intolerance to N-acetylcysteine or a non-responder after 2 months of treatment at adequate doses as determined by the clinician.\n6. Severe allergies or multiple adverse drug reactions.\n7. Current or past history of seizures.\n8. DSM-IV substance use, abuse, or dependence\n9. Any concomitant medication with primary central nervous system activity other than specified in the Concomitant Medication portion of the protocol.\n10. Current diagnosis of schizophrenia or psychosis.\n11. Females who have started menstruating.\n12. Pregnant or nursing.\n13. Judged to clinically be at serious suicidal risk or C-SSRS score ≥ 4.\n14. History of intellectual disability as reported by parent",true,"6 Years",{"count":163,"type":21},120,[165],"EARLY_PHASE1","This is a double-blind randomized controlled study. The study will last up to 16 weeks from the initial phone screen (it could take up to eight weeks to schedule and complete the initial screening process and schedule the 2 MRI visits). Once subjects have completed the screening process, they will begin the 8-week trial phase. Subjects will be assessed weekly throughout the study for efficacy and tolerability.\n\nThe investigators plan to recruit 80 participants with emotional dysregulation (ED) in the treatment arm. In addition, the investigators will aim to recruit 40age-, sex-, and parental-education matched participants without emotional dysregulation, and major psychopathology as Typically Developing (TD) control participants in the control arm.\n\nUpon scheduling the baseline visit, only the emotional dysregulation (ED) participants will be randomized 1:1 to be exposed to NAC or placebo treatment for 8 weeks. Participants will complete baseline and post-treatment (endpoint) brain MRI acquisition. TD participants will complete the same screening and characterization process as the ED group and then will be invited to complete MRI eligibility screening and to be scanned twice, separated by an eight-week interval, but the TD will not complete the NAC treatment or receive a placebo. See Table 1 (Study Schema) for a complete list of characterization measures to be completed by each group.",[28],[169,28,170],"NAC","Pediatric","2026-04-15",{"date":173,"type":45},"2026-04-17",{"date":175,"type":21},"2027-01-01",{"date":177,"type":21},"2030-01-01",{"name":179,"class":52},"Massachusetts General Hospital",2,{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":186,"acronym":187,"eligibilityCriteria":188,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":63,"enrollmentInfo":189,"targetDuration":4,"studyType":22,"phases":191,"briefSummary":192,"conditions":193,"keywords":200,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":219,"lastUpdatePostDateStruct":220,"startDateStruct":222,"completionDateStruct":224,"leadSponsor":226,"locationsCount":53},"100620990","effectiveness-of-the-soundheal-multi-sensory-integrative-therapy-among-justice-involved-youth-100620990","NCT07364799","Effectiveness of the SoundHeal Multi-Sensory Integrative Therapy Among Justice-Involved Youth","Effectiveness of the SoundHeal (Heal) Multi-Sensory Integrative Therapy in Enhancing Emotional Regulation Among Justice-Involved Youth and Its Effect on Therapeutic Alliance and Mental Health Outcomes","HEAL-SLOJSC","Inclusion Criteria:\n\n* Age: Youth 12-18 years old. All participants enrolled in this study will be under the age of 18 at time of enrollment.\n* Custody: Detained in SLO County, CA Juvenile Hall with at least 8 weeks of expected stay at the time the clinical trial starts\n* Diagnosis: Documented history of being at risk or of having a history or current diagnosis of a mental health disorder (depression, anxiety, stress) and\u002For SUD\n* Language\u002FComprehension: Basic English understanding; accommodations for limited literacy allowed\n* Consent\u002FAssent: Eligible juveniles must provide assent, with parent\u002Fguardian or Legally Authorized Representative (LAR) consent.\n* Ensure that the person providing informed consent understands the information provided, even if that person providing informed consent agrees to be in the research.\n* Participation: Willingness to comply with the Heal intervention, journaling, and questionnaires\n* Recruitment and selection participation: Eligible participants will be selected in collaboration with facility behavioral-health staff using objective inclusion criteria only. Recruitment procedures are designed to be fair and free from arbitrary influence by facility administrators or peers.\n\nSpecial Considerations: Because participants are minors and incarcerated, safeguards ensure voluntary participation, protection from coercion, age-appropriate communication, and accommodations for literacy or comprehension limits.\n\nExclusion Criteria:\n\n* Age\u002FStatus: Not between 12-18 years old, or not currently detained in SLO County Juvenile Hall\n* Length of Stay: Expected detention is less than 8 weeks at start of clinical trial\n* Clinical Stability: Determined by onsite staff to be medically or psychiatrically unable to participate safely\n* Consent\u002FAssent: Unable to provide assent, or if parent\u002Fguardian or LAR does not provide consent\n* If the person providing informed consent needs more time than is allowed by the research design.\n* Language\u002FComprehension: Cannot understand basic English, even with literacy accommodations\n* Participation: Unwilling to comply with the Heal intervention, journaling, or questionnaires\n* Research staff will not personally use the device for research purposes. Their role is limited to facilitating device use for participants and monitoring protocol adherence.\n* While the Healpod may be available for non-research use in other settings, this protocol strictly limits its use to the described research procedures. Any non-research use will be separated from this study, and no data will be collected from individuals outside of the study.\n* Currently pregnant or becomes pregnant during the study period: If pregnant or pregnancy is discovered during participation, the individual will be withdrawn from the study to prevent any potential discomfort or unknown risk exposure related to the device environment (sound, vibration, or lighting).\n\nSpecial Exclusions\n\n* Juveniles whose participation may be influenced by coercion (e.g., enrollment tied to privileges or probation decisions)\n* Juveniles with severe cognitive or behavioral impairment that prevents safe or meaningful participation",{"count":190,"type":21},12,[24],"Emotional dysregulation in justice-involved youth (JIY) is a condition that significantly impacts young people, their families, and juvenile justice and public health systems. Affecting an estimated 60-70% of detained Attention deficit hyperactivity disorderadolescents, it is a major driver of aggression, substance use, school failure, and later recidivism. Despite available treatments, managing emotional dysregulation in custody remains challenging, with youth often enduring high arousal, anger, and anxiety that persist into adulthood. Current popular therapies, including Cognitive Behavioral Therapy (CBT) and Dialectic Behavioral Therapy (DBT), often fall short in detention because they rely on verbal processing, require multiple scheduled sessions, and\u002For need highly trained staff. Other technologies, like biofeedback and neurostimulation techniques, are still under scrutiny for adolescents, given their higher-than-usual Adverse Events (AEs).\n\nThis SoundHeal study aims to evaluate a sensory intervention using the Healpod, a distraction-free physical space where a participant sits, delivering sound, music, gentle vibrations, and ambient light. Following this is a brief expressive journaling exercise to compare any before, during and after experience changes from the sensory immersion.\n\nThis prospective, single-center cohort study hypothesizes that these sessions will improve juveniles' ability to emotionally regulate, improve therapeutic alliance, mental health outcomes and build coping skills that can potentially help in long-term mental health and substance abuse treatment in JIY and beyond.",[28,194,195,196,197,198,199],"Therapeutic Alliance","Depression Disorder","Anxiety Disorders","Stress Disorders","Substance Use Disorders","Mental Health Disorders",[201,34,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218],"Emotional regulation","Justice-involved youth","Juvenile detention","Sensory-based intervention","multi-sensory stimulation therapy","Multisensory therapy","Sound therapy","music therapy","Vibroacoustic therapy","Therapeutic alliance","Therapy readiness","Mental health outcomes","substance use disorder","Coping skills","Non-verbal intervention","Journaling","Expressive Writing","Mindfulness","2026-01-16",{"date":221,"type":45},"2026-01-23",{"date":223,"type":21},"2026-01-30",{"date":225,"type":21},"2026-04",{"name":227,"class":228},"SoundHeal","INDUSTRY",{"id":230,"slug":231,"hasResults":11,"nctId":232,"briefTitle":233,"officialTitle":233,"acronym":234,"eligibilityCriteria":235,"healthyVolunteers":11,"sex":17,"minAge":63,"maxAge":4,"enrollmentInfo":236,"targetDuration":4,"studyType":22,"phases":237,"briefSummary":238,"conditions":239,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":241,"lastUpdatePostDateStruct":242,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":53},"100616815","emotional-regulation--addiction--impact-of-in-persononline-dialectic-behavior-therapy-dbt-vs-usual-treatment-100616815","NCT07310511","Emotional Regulation & Addiction : Impact of In-person\u002FOnline Dialectic Behavior Therapy (DBT) vs Usual Treatment","RégulAddict","Inclusion Criteria:\n\n* Patients aged \\>18 years\n* Patients affiliated with a social security health insurance plan\n* Patients who are fluent in French, able to understand the objectives and risks associated with the research, and able to give dated and signed informed consent\n* Patients with addictive disorders (substance and\u002For behavioral) presenting emotional dysregulation (DERS score \\>90) in the 3 months prior to the inclusion visit\n* Patients whose treatment(s) for mood disorder regulation has been stable for 3 months\n* No ongoing structured psychotherapy\n\nExclusion Criteria:\n\n* Patients diagnosed with acute psychosis\n* Patients with major neurocognitive disorders\n* Patients with encephalopathy\n* Patients in a period of exclusion (determined by a previous or ongoing study)\n* Patients in an emergency\u002Flife-threatening situation\n* Patients under legal protection\n* Pregnancy (self-reported)\u002Fbreastfeeding",{"count":163,"type":21},[24],"In psychiatry, psychotherapy is, along with pharmacotherapy, a major therapeutic intervention. It helps patients better understand their difficulties and informs them of possible solutions. It is systematically recommended in cases of psychiatric disorders, whether or not in combination with pharmacotherapy.\n\nWith regard to addictive disorders in particular, few medications are available and psychotherapy is essential. Psychotherapy must be adapted to the severity of the patient's condition and the issues encountered. In cases of impaired emotional regulation, i.e., the ability to respond effectively to one's emotions, addictions become more difficult to stabilize without appropriate treatment. For patients with emotional regulation disorders, Dialectical Behavior Therapy (DBT) is the standard treatment. It consists of teaching acceptance and change skills in a dialectical manner to better regulate emotions.\n\nLike other evidence-based psychotherapies, DBT is nevertheless not widely available. It requires therapists to have a high level of training and sufficient patient recruitment to form groups. Two solutions are being considered to improve the accessibility of DBT. To facilitate patient recruitment, transdiagnostic groups are useful because they bring together patients with different diagnoses. To help professionals deliver the therapy, digital tools such as pre-recorded videos or mobile applications have proven effective, particularly when guided by a therapist, but they also show some effectiveness without a therapist. Studies are still recent and few in number, and need to be replicated, particularly using a variety of digital tools.\n\nThe investigators want to evaluate the effectiveness of DBT on emotional regulation and impulsivity in addiction patients, in a transdiagnostic face-to-face format and in an online format using videos, compared to a control group (usual treatment). This research would provide a better understanding of the effectiveness of DBT in addiction treatment, as well as the effectiveness of solutions that improve its accessibility, such as the transdiagnostic format and the use of associated digital tools.",[240,28],"Addiction Disorders","2025-12-15",{"date":243,"type":45},"2025-12-30",{"date":245,"type":21},"2026-01",{"date":247,"type":21},"2030-04",{"name":249,"class":52},"University Hospital, Strasbourg, France",{"id":251,"slug":252,"hasResults":11,"nctId":253,"briefTitle":254,"officialTitle":254,"acronym":255,"eligibilityCriteria":256,"healthyVolunteers":11,"sex":17,"minAge":257,"maxAge":258,"enrollmentInfo":259,"targetDuration":261,"studyType":67,"phases":4,"briefSummary":262,"conditions":263,"keywords":269,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":275,"lastUpdatePostDateStruct":276,"startDateStruct":278,"completionDateStruct":280,"leadSponsor":281,"locationsCount":53},"100613984","assessing-real-life-effectiveness-of-treatment-in-neurodevelopmental-disorders-100613984","NCT07273695","Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders","ALERT","Inclusion Criteria\n\n* Children and adolescents aged 8-15 years;\n* Diagnosis of externalizing disorder, ADHD, and\u002For emotional dysregulation (assessed with questionnaires, interviews, and\u002For clinical observation);\n* Intelligence quotient ≥ 75.\n\nExclusion Criteria\n\n* IQ \\\u003C 75;\n* Substance abuse and addictions;\n* Psychosis;\n* Acute disorders;\n* Organic brain disorders;\n* Presence of neurological diseases, epilepsy;\n* Genetic syndromes;\n* Co-diagnosis with other psychiatric or neurodevelopmental disorders (e.g., autism, anxiety, depression, etc.) and prior psychopharmacological therapy will not be considered exclusion criteria but will be recorded and declared.","8 Years","15 Years",{"count":260,"type":21},80,"9 Months","The goal of this observational study is to learn if and how pharmacological and psychotherapeutic group treatments can treat clinical symptoms of children and adolescent patients with ADHD.\n\nThe main questions it aims to answer are:\n\n* Are pharmacological and psychotherapeutic treatments effective on the clinical symptoms of patients with ADHD?\n* Are pharmacological and psychotherapeutic treatments effective on symptoms of emotion-behavioral dysregulation?\n* Is it possible to find associations between individual characteristics and treatment responses evaluating behavioral and neural correlates in children and adolescents with traits of emotion-behavioral dysregulation, externalizing disorders, and\u002For ADHD, using a panel of multimodal measures. May the data collected contribute to the definition of profiles useful for generating predictive hypotheses aimed at developing more personalized interventions?\n\nResearchers will compare the data collected from patients treated with pharmacological and psychotherapeutic group treatments with the data of subjects of comparable sex\u002Fgender, age, diagnoses, on the waiting list for treatment to see if pharmacological and psychotherapeutic treatments effects ADHD and emotional dysregulation symprtoms.\n\nParticipants, patients who are offered treatment by clinicians according to standard clinical practice, will be asked to participate in the study by undergoing experimental assessments before and after the treatment.\n\nThe multimodal panel of proposed assessments includes:\n\n* behavioral assessments, conducted through the completion of clinical and socio-demographic questionnaires;\n* neuropsychological assessments, conducted through standardized computerized neuropsychological tests;\n* neurophysiological assessments, conducted through the recording of NIRS (near infrared spectroscopy) and EEG (electroencephalogram) signals during an attentional task (Go-NoGo) and via a smartwatch.",[28,264,265,266,267,268],"Externalizing Problems","Oppositional Defiant","Conduct Disorder","Disruptive Behaviours","Attention Deficit Hyerpactivity Disorder",[270,271,272,273,274],"attention deficit hyperactivity disorder","child training","methylphenidate","emotional dysregulation","externalizing disorders\u002Fbehaviors","2025-11-28",{"date":277,"type":45},"2025-12-09",{"date":279,"type":45},"2025-09-19",{"date":49,"type":21},{"name":282,"class":52},"IRCCS Eugenio Medea",{"id":284,"slug":285,"hasResults":11,"nctId":286,"briefTitle":287,"officialTitle":288,"acronym":4,"eligibilityCriteria":289,"healthyVolunteers":11,"sex":17,"minAge":63,"maxAge":290,"enrollmentInfo":291,"targetDuration":4,"studyType":22,"phases":293,"briefSummary":294,"conditions":295,"keywords":301,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":308,"lastUpdatePostDateStruct":309,"startDateStruct":310,"completionDateStruct":312,"leadSponsor":314,"locationsCount":53},"100611344","culturally-adapted-dialectical-behavior-therapy-for-low-middle-income-countries-100611344","NCT07239362","CULTURALLY ADAPTED DIALECTICAL BEHAVIOR THERAPY FOR LOW-MIDDLE-INCOME COUNTRIES","Culturally Adapted Dialectical Behavior Therapy (DBT) for Mental Health in LMICs: A Randomized Controlled Trial (RCT)","Inclusion Criteria:\n\n* Adults aged 18-45 years\n* Adults who are diagnosed with or have significant traits of borderline personality disorder (BPD)\n* Adults who are willing to provide written informed consent\n\nExclusion Criteria:\n\n* Severe psychiatric comorbidity (e.g., active psychosis, substance use, etc.)\n* Acute medical conditions interfering with participation\n* Lack of basic reading and writing, or any learning disability","45 Years",{"count":292,"type":21},220,[24],"The study aims to assess the efficacy of culturally adapted dialectical behaviour therapy (DBT) for addressing emotional dysregulation in a low- and middle-income country, as well as to evaluate the impact of DBT on secondary outcomes such as borderline personality traits, self-harm or suicide, depression, anxiety, and individuals' functioning and disability.\n\nThrough a rigorous Randomised Controlled Trial (RCT), the research seeks to assess how cultural adaptations of dialectical behaviour therapy improve its applicability, engagement, and outcomes in diverse socio-cultural settings, contributing to more accessible and effective mental health interventions in resource-limited regions.",[296,297,28,298,299,300],"Borderline Personality Disorder (BPD)","Dialectical Behavior Therapy","Self Harm","Suicidal and Self-injurious Behavior","Depression Anxiety Disorder",[302,303,304,305,306,307,34],"BPD","DBT","Self harm","Suicide","Borderline personality","Dialectical behavior therapy","2025-11-22",{"date":275,"type":45},{"date":311,"type":21},"2025-11-20",{"date":313,"type":21},"2026-07-31",{"name":315,"class":52},"Pakistan Association of Cognitive Therapists",{"id":317,"slug":318,"hasResults":11,"nctId":319,"briefTitle":320,"officialTitle":321,"acronym":4,"eligibilityCriteria":322,"healthyVolunteers":160,"sex":17,"minAge":323,"maxAge":324,"enrollmentInfo":325,"targetDuration":4,"studyType":22,"phases":327,"briefSummary":328,"conditions":329,"keywords":331,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":336,"lastUpdatePostDateStruct":337,"startDateStruct":339,"completionDateStruct":341,"leadSponsor":343,"locationsCount":53},"100596054","child-parent-psychotherapy-after-the-2023-kahramanmara-earthquake-100596054","NCT07040462","Child-Parent Psychotherapy After the 2023 Kahramanmaraş Earthquake","Child-Parent Psychotherapy for Post-Earthquake Trauma in Preschool Children: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Children aged 3 to 6 years old at the time of enrollment\n* Resided in one of the 11 cities affected by the 2023 Kahramanmaraş earthquake (e.g., Hatay, Kahramanmaraş, Adıyaman, Malatya, Gaziantep, Şanlıurfa, Adana, Osmaniye, Diyarbakır, Kilis, Elazığ)\n* Exposure to at least one qualifying traumatic event due to the earthquake (e.g., witnessing injury or death, loss of home, separation from caregiver)\n* Living with a primary caregiver (mother or father) who consents to participate in the study\n* Both caregiver and child are available to participate in 12 weekly sessions of CPP (online or face-to-face)\n* Caregiver is fluent in Turkish and able to complete self-report questionnaires\n\nExclusion Criteria:\n\n* Child or caregiver currently receiving psychotherapy or psychiatric treatment\n* Child diagnosed with developmental disorder (e.g., autism, intellectual disability) that significantly impairs communication or relational functioning\n* Caregiver with a diagnosed severe psychiatric disorder (e.g., psychosis, bipolar disorder) or active substance use disorder\n* Families with ongoing legal custody disputes or instability that may interfere with consistent participation\n* Inability to access internet or digital device (for participants randomized to online therapy)","3 Years","65 Years",{"count":326,"type":21},60,[24],"This study aims to evaluate the effectiveness of Child-Parent Psychotherapy (CPP) in reducing trauma-related symptoms and improving attachment quality among preschool-aged children who experienced the 2023 Kahramanmaraş earthquakes in Türkiye. A total of 60 caregiver-child dyads (children aged 3-6) will be recruited from 11 earthquake-affected provinces. Participants will be randomly assigned to either the intervention group, receiving 12 weekly CPP sessions, or a no-intervention control group. CPP will be delivered by trained clinical psychologists through either online or face-to-face sessions. Assessments will be conducted at baseline, mid-intervention (after session 6), and post-intervention (after session 12). Outcomes include child trauma symptoms, social-emotional functioning, and attachment quality, as well as caregiver reflective functioning, stress, and emotional well-being.",[330,28],"Post-Traumatic Stress Disorder Complex",[332,333,334,335],"Child-Parent Psychotherapy (CPP)","Trauma Therapy","Preschool Children","Kahramanmaraş Earthquake","2025-06-18",{"date":338,"type":45},"2025-06-27",{"date":340,"type":45},"2025-06-15",{"date":342,"type":21},"2025-11-15",{"name":344,"class":52},"Beykoz University",{"id":346,"slug":347,"hasResults":11,"nctId":348,"briefTitle":349,"officialTitle":350,"acronym":4,"eligibilityCriteria":351,"healthyVolunteers":160,"sex":17,"minAge":352,"maxAge":353,"enrollmentInfo":354,"targetDuration":4,"studyType":67,"phases":4,"briefSummary":356,"conditions":357,"keywords":360,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":369,"lastUpdatePostDateStruct":370,"startDateStruct":372,"completionDateStruct":374,"leadSponsor":376,"locationsCount":4},"100590344","co-producing-lgbtq-affirmative-dbt-protocols-100590344","NCT06966193","Co-Producing LGBTQ-Affirmative DBT Protocols.","Co-Producing LGBTQ-Affirmative Intervention Protocols for LGBTQ+ People at Risk of Self-Harm and Suicide: A Co-Production Study","DBT Cohort Young Person Sample 1\n\nInclusion criteria will include that the young person:\n\n1. Is aged 13 to 21 years old;\n2. has completed at least four months of comprehensive DBT (i.e. inclusive of all four modes of intervention; Linehan, 1993; Miller et al., 2006; Rathus \\& Miller, 2015) in the past 24 months or have completed at least four months of DBT and are still in a comprehensive DBT programme;\n3. identifies as LGBTQ+ (including those questioning or unsure about their orientation\u002Fidentity);\n4. is willing and able to participate in the study. While no specific inclusion or exclusion criteria will be placed on other variables, typically to be eligible for a DBT programme, young people would need to have a history of self-harm and\u002For suicidal behaviours, difficulties with emotion regulation, and potentially difficulties with the remaining symptom list within borderline\u002Femotionally unstable personality disorder. Recruitment size is based on PPI recommendations regarding effective group sizes, with allowances for sample attrition.\n\nNon-DBT Cohort Young Person Sample 2\n\nInclusion criteria will follow similar to sample 1. The young person:\n\n1. Is aged 13 to 21 years old;\n2. has not accessed and is not currently enrolled in a comprehensive DBT programme;\n3. has experienced difficulties with LGBTQ-related identity confusion, managing stigma experiences, and connecting with similar others;\n4. identifies as LGBTQ+ (including those questioning or unsure about their orientation\u002Fidentity);\n5. is willing and able to participate in the study (i.e. are based in the UK and can attend the in-person and online groups).\n\nNo other inclusion or exclusion criteria will be systematically implemented for this group.\n\nDBT Therapist Sample\n\nInclusion criteria:\n\n1. Currently practicing or having completed (or recently finished, within the past 12 months) a comprehensive DBT programme as a DBT therapist. In order to practice as a DBT therapist, they must hold a professional qualification recognised by appropriate healthcare regulators.\n2. Having experience working with at least one LGBTQ+ client in DBT, who was aged between 13 and 21 years at the time.\n3. Being willing and able to participate in the study.","13 Years","21 Years",{"count":355,"type":21},32,"Aims:\n\n1. To co-produce new intervention parts that meet the needs of LGBTQ+ people at risk of self-harm or suicidal thoughts, with LGBTQ+ people and DBT therapists. These intervention parts will be integrated into a Dialectical Behaviour Therapy (DBT) intervention, that is provided earlier in a persons mental health care journey, than DBT is usually targeted at.\n2. To assess how acceptable and feasible the co-production process was for participants, and how well it achieved co-production principles (e.g. participants feel supported, that the aims were transparent, etc).\n\nWhy is This Important? Young people who identify as lesbian, gay, bisexual, transgender, queer, and with other minoritised gender and sexual identities (LGBTQ+) are much more likely to self-harm and experience suicidal thoughts than cisgender-heterosexual (non-LGBTQ+) people. They also experience barriers when accessing mental health support. Some of these barriers come from a lack of support tailored towards their needs as an LGBTQ+ person. This often means that things get worse before they access the right support, and so are often seen in higher-intensity interventions (tier 4 or tertiary care), like DBT.\n\nWhat The Investigators Plan to Do:\n\nThe investigators plan to hold some focus groups with three different groups of people to co-produce the new intervention parts. The three groups include:\n\n1. A group of LGBTQ+ young people (13-21 years old) who have completed a at full DBT programme recently.\n2. A group of LGBTQ+ young people (13-21 years old) who have never been in a full DBT programme but experienced similar difficulties.\n3. A group of DBT therapists who have supported LGBTQ+ young people before.\n\nThe investigators will seek feedback from participants about how acceptable they found the study (e.g. how satisfied they were with the process), how feasible it was (e.g. were they able to attend and was it practice?), and how well they stuck to the coproduction principles (e.g. how supported they felt).",[358,359,28],"Self-Harm","Suicidal",[361,303,358,362,363,364,365,366,367,135,368],"LGBTQ+","Suicidal Behaviours","Emotion Dysregulation","Young People","Sexual Minorities","Gender Minorities","Co-Production","Therapists","2025-05-12",{"date":371,"type":45},"2025-05-15",{"date":373,"type":21},"2025-10-01",{"date":375,"type":21},"2026-07-30",{"name":377,"class":52},"King's College London",{"id":379,"slug":380,"hasResults":11,"nctId":381,"briefTitle":382,"officialTitle":383,"acronym":4,"eligibilityCriteria":384,"healthyVolunteers":11,"sex":17,"minAge":352,"maxAge":63,"enrollmentInfo":385,"targetDuration":4,"studyType":22,"phases":387,"briefSummary":388,"conditions":389,"keywords":391,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":393,"lastUpdatePostDateStruct":394,"startDateStruct":396,"completionDateStruct":398,"leadSponsor":400,"locationsCount":53},"100572485","music-therapy-for-adolescents-with-emotional-difficulties-100572485","NCT06733883","Music Therapy for Adolescents with Emotional Difficulties","\"I've Got the Music in Me.\" Music Therapy for Adolescents with Emotional Difficulties: a Clinical Study","Inclusion criteria:\n\n* adolescents 13 to 18 years\n* emotional difficulties\n\nExclusion criteria:\n\n* autism spectrum disorder\n* mental retardation\n* severe depressive episode combined with high suicidal risk",{"count":386,"type":21},20,[24],"The goal of this clinical trial is to examine the effects of a music therapy program in adolescents aged 13-18 years old with emotional difficulties, primarily depression and possibly concurrent diagnoses of anxiety.\n\nThe main questions are:\n\n* What recruitment methods, barriers, and facilitators influence study participation among adolescents with emotional difficulties receiving music therapy in the present study?\n* Does music therapy contribute to a significant reduction in depression and anxiety symptoms, inclusive concomitant symptoms?\n* How do adolescents with emotional disorders perceive participation in music therapy, and how do they articulate its potential impacts on their health and well-being?\n\nParticipants will be invited to participate in a music therapy program, in addition to standard treatment given (TAU). They meet individually in the clinic with a professional music therapist once a week over a period of ten weeks. They will also do musical home exercises between the sessions. Psychiatric interviews and clinical assessments will be conducted before treatment. Assessments and questionnaires will be performed right after the therapy program and three months after ended therapy. There will also be conducted qualitative interviews with a subgroup of the participants.",[390,28],"Depressive Disorder",[392,135,34,106],"Music therapy","2024-12-10",{"date":395,"type":45},"2024-12-13",{"date":397,"type":45},"2023-10-09",{"date":399,"type":21},"2028-06",{"name":401,"class":52},"Oslo University Hospital",{"id":403,"slug":404,"hasResults":11,"nctId":405,"briefTitle":406,"officialTitle":407,"acronym":4,"eligibilityCriteria":408,"healthyVolunteers":160,"sex":17,"minAge":63,"maxAge":324,"enrollmentInfo":409,"targetDuration":4,"studyType":22,"phases":410,"briefSummary":411,"conditions":412,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":413,"lastUpdatePostDateStruct":414,"startDateStruct":416,"completionDateStruct":417,"leadSponsor":419,"locationsCount":4},"100378676","effectiveness-and-security-testing-of-a-mobile-app-for-self-managing-emotion-dysregulation-100378676","NCT04210648","Effectiveness and Security Testing of a Mobile App for Self-Managing Emotion Dysregulation","Effectiveness and Security Testing of a Mobile App for Self-Managing Emotion Dysregulation in a Non-Clinical Population With Borderline Traits: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Borderline traits\n* Aged between 18 to 65 years\n* College students\n\nExclusion Criteria:\n\n* None",{"count":260,"type":21},[24],"To assess the effectiveness and security of a mobile App (beta version) for people with borderline traits recruited from a non-clinical population of college students in Barcelona (Spain). The main primary outcome will be the severity of the emotional dysregulation. Forty participants will use the mobile app over 6 months. This group while be compared at post-treatment and at 3-month follow-up with other 40 participants (control group) with any intervention.",[28],"2024-09-12",{"date":415,"type":45},"2024-09-19",{"date":87,"type":21},{"date":418,"type":21},"2028-10",{"name":420,"class":52},"Consorci Sanitari del Maresme"]